GALEOTTI, FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.057
EU - Europa 3.230
AS - Asia 3.011
SA - Sud America 446
AF - Africa 101
OC - Oceania 40
Continente sconosciuto - Info sul continente non disponibili 8
Totale 12.893
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.969
GB - Regno Unito 1.274
SG - Singapore 1.000
CN - Cina 694
IT - Italia 611
HK - Hong Kong 381
BR - Brasile 333
DE - Germania 246
SE - Svezia 246
TR - Turchia 225
VN - Vietnam 172
FR - Francia 119
RU - Federazione Russa 118
UA - Ucraina 111
FI - Finlandia 99
ID - Indonesia 88
IN - India 77
KR - Corea 74
BG - Bulgaria 68
AR - Argentina 55
JP - Giappone 51
PL - Polonia 44
CA - Canada 42
GR - Grecia 39
TH - Thailandia 34
AU - Australia 31
MX - Messico 31
IR - Iran 30
PK - Pakistan 30
MY - Malesia 29
CH - Svizzera 28
ES - Italia 28
NL - Olanda 24
LT - Lituania 23
RS - Serbia 20
DZ - Algeria 19
ZA - Sudafrica 19
TN - Tunisia 18
BE - Belgio 17
EG - Egitto 17
PT - Portogallo 17
AT - Austria 16
QA - Qatar 15
CL - Cile 14
DK - Danimarca 14
MA - Marocco 13
RO - Romania 13
UZ - Uzbekistan 12
BD - Bangladesh 11
CO - Colombia 11
IQ - Iraq 11
PH - Filippine 11
SI - Slovenia 11
IE - Irlanda 10
TW - Taiwan 10
VE - Venezuela 10
NZ - Nuova Zelanda 9
IL - Israele 8
SA - Arabia Saudita 8
HR - Croazia 7
LB - Libano 7
AE - Emirati Arabi Uniti 6
CZ - Repubblica Ceca 6
EC - Ecuador 6
EU - Europa 6
BO - Bolivia 5
ET - Etiopia 5
MO - Macao, regione amministrativa speciale della Cina 5
PE - Perù 5
CU - Cuba 4
JO - Giordania 4
NO - Norvegia 4
PY - Paraguay 4
AL - Albania 3
AM - Armenia 3
AZ - Azerbaigian 3
CR - Costa Rica 3
KZ - Kazakistan 3
MK - Macedonia 3
NG - Nigeria 3
SM - San Marino 3
UY - Uruguay 3
GT - Guatemala 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GM - Gambi 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
KH - Cambogia 1
Totale 12.882
Salva come PNG Salva come JPEG
Città #
Southend 944
Singapore 733
Fairfield 716
Santa Clara 702
Ashburn 572
Woodbridge 466
Chandler 458
Hong Kong 375
Houston 311
Seattle 277
Cambridge 235
Dearborn 222
Wilmington 221
Nyköping 210
London 161
Jacksonville 155
Ann Arbor 151
Beijing 150
Modena 140
Hefei 86
Izmir 81
New York 81
Redwood City 61
Sofia 61
Jakarta 56
Los Angeles 56
Princeton 55
Eugene 54
Council Bluffs 51
Helsinki 51
Ho Chi Minh City 51
San Diego 41
Dong Ket 40
Leipzig 40
Shanghai 40
The Dalles 40
Istanbul 37
Hanoi 32
Moscow 31
Buffalo 30
Munich 30
Milan 29
São Paulo 28
Seoul 27
Tokyo 27
Hillsboro 23
Bangkok 21
Columbus 21
Nuremberg 19
Ankara 18
Belgrade 18
Jinan 18
Turku 18
Redondo Beach 17
Belo Horizonte 16
Dallas 15
Doha 15
Rome 15
Brussels 14
Guangzhou 14
Chicago 13
Delhi 13
Florence 13
Paris 13
Parma 13
Rio de Janeiro 13
Falkenstein 12
Falls Church 12
Kunming 12
San Giuliano Milanese 12
Stockholm 12
Zhengzhou 12
Boardman 11
Bologna 11
Curitiba 11
Madrid 11
Perugia 11
Tashkent 11
Athens 10
Erzurum 10
Ottawa 10
Poznan 10
San Francisco 10
Sydney 10
Thessaloniki 10
Bradford 9
Brasília 9
Lahore 9
Manchester 9
Nanjing 9
Naples 9
Taipei 9
Warsaw 9
Amsterdam 8
Barcelona 8
Boston 8
Chiang Mai 8
Montreal 8
Phoenix 8
Wuhan 8
Totale 9.091
Salva come PNG Salva come JPEG
Nome #
ACTIVITY STUDIES OF CHARACTERIZED, STANDARDIZED AND HIGHLY PURIFIED PROPOLIS EXTRACT 622
Recent advances in analytical approaches for the standardization and quality of polyphenols of propolis 542
Chemical Composition and Antioxidant Activity of Propolis Prepared in Different Forms and in Different Solvents Useful for Finished Products 450
MOLECULAR COMPOSITION OF ACTIVE CHIOS MASTIC GUM COMPOUNDS, TERPENES, FOR USE IN COSMETIC, NUTRACEUTICAL, MEDICAL DEVICES AND PHARMACEUTICAL APPLICATIONS. 398
Differences among Three Branded Formulations of Hyaluronic Acid: Data from Environmental Scanning Electron Microscope Profile, Rheology Behavior and Biological Activity 360
Purification and structural elucidation of chondroitin sulfate/dermatan sulfate from Atlantic bluefin tuna (Thunnus thynnus) skins and their anticoagulant and ACE inhibitory activities 305
Chondroitin sulfate/dermatan sulfate from corb (Sciaena umbra) skin: Purification, structural analysis and anticoagulant effect 286
Analytical Methods for Assessing Chondroitin Sulfate in Human Plasma. 281
Isolation, Purification and Structural Characterestics of Chondroitin Sulfate from Smooth hound Cartilage: In vitro Anticoagulant and Antiproliferative Properties 277
Mental retardation in mucopolysaccharidoses correlates with high molecular weight urinary heparan sulphate derived glucosamine. 275
Capillary electrophoresis separation of human milk neutral and acidic oligosaccharides derivatized with 2-aminoacridone. 272
Biological effects and potential mechanisms of action of Pistacia lentiscus Chios mastic extract in Caco-2 cell model 263
Recent advances on separation and characterization of human milk oligosaccharides. 252
Purification, Structural Characterization and Antiproliferative Properties of Chondroitin Sulfate/Dermatan Sulfate from Tunisian Fish Skins 251
Purification, compositional analysis, and anticoagulant capacity of chondroitin sulfate/dermatan sulfate from bone of corb (Sciaena umbra). 250
Comparative analysis of fatty acid profile in three eutardigrade species 245
Isolation and structural characterization of chondroitin sulfate from bony fishes 244
Characterization of Oversulfated Chondroitin Sulfate Rich in 4,6-O-disulfated Disaccharides in Breast Cyst Fluids Collected from Human Breast Gross Cysts. 242
Recent advances in capillary electrophoresis separation of monosaccharides, oligosaccharides and polysaccharides 237
Selective treatment to reduce contamination of propolis by polycyclic aromatic hydrocarbons (PAHs) still preserving its active polyphenol component and antioxidant activity 232
Analysis of glycosaminoglycan-derived, pre-column 2-aminoacridone-labeled disaccharides using liquid chromatography-fluorescence and -mass spectrometric detection. 231
Multi dynamic extraction: An innovative method to obtain a standardized chemically and biologically reproducible polyphenol extract from poplar-type propolis to be used for its anti-infective properties 231
Metabolic fate of milk glycosaminoglycans in breastfed and formula fed newborns. 230
Plasmatic kinetics of dermatan sulfate during enzyme replacement therapy with iduronate-2-sulfatase in a mucopolysaccharidosis II Patient 225
Novel reverse-phase ion pair-high performance liquid chromatography separation of heparin, heparan sulfate and Low molecular weight-heparins disaccharides and oligosaccharides. 222
Plasmatic and urinary glycosaminoglycan profile in a patient affected by multiple sulfatase deficiency 221
Mild mental retardation and low levels of urinary heparan sulfate in a patient with the attenuated phenotype of Mucopolysaccharidosis type IIIA. 218
Composition and structure of glycosaminoglycans in DBS from 2-3-day-old newborns for the diagnosis of mucopolysaccharidosis 218
Total and single species of uronic acid-bearing glycosaminoglycans in urine of newborns of 2-3 days of age for early diagnosis application 214
Glycosaminoglycan levels and structure in a mucopolysaccharidosis IIIA mice and the effect of a highly secreted sulfamidase engineered to cross the blood-brain barrier 214
Human milk glycosaminoglycans: the state of the art and future perspectives 213
Glycosaminoglycan profiling as a novel pan-cancer minimally invasive systems biomarker. 213
Studies on European eel skin sulfated glycosaminoglycans: Recovery, structural characterization and anticoagulant activity 212
Plasma glycosaminoglycans as diagnostic and prognostic biomarkers in surgically treated renal cell carcinoma 208
Plasmatic dermatan sulfate and chondroitin sulfate determination in mucopolysaccharidoses 207
High quality Green (Brazilian) propolis extracts characterized for active biomolecules exert epigenetic effects able to have a positive influence on cell oxidative stress 197
Water Soluble Ppropolis (Greit120) and Human Interferon – α (HuIFN-AlfaN3) shows Anti – Influenza virus activity in vitro 192
PURIFICATION OF PROPOLIS FROM POLYCYCLIC AROMATIC HYDROCARBONS AND PRESERVATION OF ACTIVE POLYPHENOL COMPONENT. 192
Mucopolysaccharidosis type II: preliminary data on glycosaminoglycan levels and structure in mice at baseline and after 6 weeks treatment with ERT 189
Breast Cyst Fluid Heparan Sulfate is Distinctively N-sulfated Depending on Apocrine or Flattened Type 187
Selective removal of keratan sulfate in chondroitin sulfate samples by sequential precipitation with ethanol 178
Human milk glycosaminoglycans. Handbook on dietary and nutritional aspects of human breast milk 178
Plasma glycosaminoglycan scores in early stage renal cell carcinoma 177
Oligosaccharide mapping of heparinase I-treated heparins by hydrophilic interaction liquid chromatography separation and online fluorescence detection and electrospray ionization-mass spectrometry characterization. 172
Chemical composition and antioxidant activity of propolis prepared in different forms and in different solvents useful for finished products 168
Oral bioavailability and pharmacokinetic of non-animal chondroitin sulfate and its constituents in healthy male volunteers 162
Structural definition of terrestrial chondroitin sulfate of various origin and repeatability of the production process 156
High-throughput determination of urinary hexosamines in newborns of 2-3 days of age: application for the early diagnosis of mucopolysaccharidoses 152
Determination of total and single species of all uronic acid-bearing glycosaminoglycans in urine of newborns of 2-3 days of age for a possible early diagnosis of mucopolysaccharidoses 149
CHARACTERIZED PROPOLIS EXTRACTS, OBTAINED WITH STANDARDIZED EXTRACTION METHOD, SHOWN SIMILAR CHEMICAL PROFILE (HPLC-ESI-MSN) AND IN VITRO ANTIBACTERIAL, ANTIOXIDANT AND ANTI-INFLAMMATORY ACTIVITY TROUGH EVALUATION OF EXPRESSION OF miRNAS, mRNAS AND PROTEINS 148
Rigon L, Maccari F, Salvalaio M, Legnini E, D’Avanzo F, Galeotti F, Mantovani V, Gabrielli O, Marin O, Scarpa M, Volpi N, Tomanin R. Glycosaminoglycan profile in the Mucopolysaccharidosis type II mouse model at baseline and after 6 weeks treatment with ERT 147
Variazioni del dermatan solfato plasmatico durante la terapia enzimatica sostitutiva con iduronato-2-solfatasi in un paziente affetto da mucopolisaccaridosi II 145
Approccio globale alle mucopolisaccaridosi: creazione piattaforma web-based 138
Propolis: innovation and new applications based on its fine structural composition 137
Human milk glycosaminoglycan composition from women of different countries: a pilot study 114
Noninvasive detection of any-stage cancer using free glycosaminoglycans 84
Urinary Free Glycosaminoglycans Identify Adults at High Risk of Developing Early-stage High-grade Bladder Cancer 68
Mucopolisaccaridosi: approcci analitici alla diagnosi asintomatica. 46
Totale 13.037
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.126
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.126
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.170 0 0 0 0 0 316 121 205 97 198 127 106
2021/20221.064 52 120 70 53 32 55 46 44 169 106 171 146
2022/20231.368 128 147 103 147 113 192 25 179 152 24 67 91
2023/20241.163 49 67 44 178 237 102 115 136 27 41 63 104
2024/20252.689 100 76 56 184 541 397 183 198 299 112 212 331
2025/20261.809 174 96 299 416 767 57 0 0 0 0 0 0
Totale 13.037